விவோஸ் சிகிச்சை இன்க் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from விவோஸ் சிகிச்சை இன்க். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In விவோஸ் சிகிச்சை இன்க் Today - Breaking & Trending Today

Vivos Therapeutics : Announces Closing of Follow-On Offering and Exercise in Full of the Underwriters' Option to Purchase Additional Shares (Form 8-K)


Message :
Required fields
Vivos Therapeutics Announces Closing of Follow-On Offering and Exercise in Full of the Underwriters Option to Purchase Additional Shares
HIGHLANDS RANCH, Colo., May 11, 2021 - Vivos Therapeutics, Inc. (Nasdaq: VVOS) ( Vivos ), a medical technology company focused on developing and commercializing innovative treatments for patients suffering from sleep-disordered breathing, including mild-to-moderate obstructive sleep apnea (OSA), today announced the closing of its underwritten follow-on public offering of 4,600,000 shares of its common stock. The offering consisted of 4,000,000 shares of its common stock, as well as an additional 600,000 shares pursuant to the exercise in full of the underwriters option to purchase additional shares of common stock, at a public offering price of $6.00 per share. ....

New York , United States , Caitlin Kasunich Jenny Robles , Edward Loew , Exchange Commission On , Craig Hallum Capital Group , Exchange Commission , Vivos Therapeutics Inc , Prospectus Department , Strategic Communications , National Securities Corporation , Vivos Therapeutics Announces Closing , Follow On Offering , Underwriter Option , Purchase Additional , Capital Partners , Securities Corporation , Roth Capital Partners , Clemente Drive , Newport Beach , Ninth Street , Equity Capital Markets , Vivos Therapeutics , Vivos System , Apnea Hypopnea Index , Vivos Integrated Practice ,

Vivos Therapeutics Announces Pricing of $24 Million Follow-On Offering


Vivos Therapeutics Announces Pricing of $24 Million Follow-On Offering
HIGHLANDS RANCH, Colo., May 06, 2021 (GLOBE NEWSWIRE) Vivos Therapeutics, Inc. (Nasdaq: VVOS) (“Vivos”), a medical technology company focused on developing and commercializing innovative treatments for patients suffering from sleep-disordered breathing, including mild-to-moderate obstructive sleep apnea (OSA), today announced the pricing of its underwritten follow-on public offering of 4,000,000 shares of its common stock at a public offering price of $6.00 per share.
The aggregate gross proceeds to Vivos from the public offering are expected to be $24 million prior to deducting underwriting discounts, commissions, and other estimated offering expenses. Vivos has granted the underwriters a 45-day option to purchase up to an additional 600,000 shares of common stock to cover over-allotments, if any. ....

New York , United States , Caitlin Kasunich Jenny Robles , Edward Loew , Exchange Commission , Strategic Communications , Prospectus Department , Vivos Therapeutics Inc , National Securities Corporation , Craig Hallum Capital Group , Vivos Therapeutics , Capital Partners , Securities Corporation , Roth Capital Partners , Newport Beach , Ninth Street , Equity Capital Markets , Vivos System , Apnea Hypopnea Index , Vivos Integrated Practice , Private Securities Litigation Reform Act , Relations Contacts , புதியது யார்க் , ஒன்றுபட்டது மாநிலங்களில் , எட்வர்ட் குறைந்த , பரிமாற்றம் தரகு ,